Bioventures Institute

the bioventures institute is an innovation-driven molecular biotechnology company, conducting applied research, product development and production, utilizing advanced genetic engineering, molecular biology, biochemical and microbiological technologies. bioventures institute developed dna-face™ (dna fragment amplification & concatemeric expressed nucleic acids and proteins) technology. dna-face™ is a universal biotechnological platform, created with the use of genetic engineering methods, based on directional, ordered amplification of natural or designed dna fragments, coding for a specific function. this isothermal enzymatic reaction leads to the construction of targeted, concatemeric biological macromolecules, including dna, rna, proteins. dna-face™ is applicable to the development of new generation, protein- or mrna-based vaccines, genetically programmed dna, rna, mrna, proteins and biological drugs, as well as to industrial and environmental processes.